The U.S. Department of Defense has stopped using Anthropic AI tools following a blacklisting decision, according to BBC reporting. This action occurs as Anthropic faces increased regulatory pressure in multiple jurisdictions, including Australia, while simultaneously securing record-breaking capital from Wall Street banks for chip infrastructure development. For healthcare AI deployments, particularly those serving federal healthcare systems or defense-affiliated medical facilities, this signals rising compliance complexity around vendor selection and government approval processes. Healthcare organizations relying on Anthropic's models for clinical workflows or EHR integration should reassess their regulatory risk exposure and contingency planning. The concurrent scrutiny over data practices and copyright obligations creates additional due diligence requirements for health systems evaluating enterprise AI vendors.